Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Moehler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Biotechnology|December 16, 2006
Thalidomide in multiple myelomaT M Moehler, J Hillengass, A Glasmacher, et al.
Critical Reviews in Oncology/Hematology|March 14, 2003
Angiogenesis in hematologic malignanciesT M Moehler, A D Ho, H Goldschmidt, et al.
Annals of Hematology|January 18, 2002
Angiogenesis in hematologic malignanciesT M Moehler, K Neben, A D Ho, et al.
Current Pharmaceutical Design|April 14, 2004
Antiangiogenic therapy in hematologic malignanciesT M Moehler, J Hillengass, H Goldschmidt, et al.
International Journal of Hematology|October 11, 2008
Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitisJ Hillengass, A D Ho, H Goldschmidt, et al.
Blood|December 12, 2001
Salvage therapy for multiple myeloma with thalidomide and CED chemotherapyT M Moehler, K Neben, A Benner, et al.
Der Radiologe|September 28, 2000
[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma]T M Moehler, H Hawighorst, K Neben, et al.
International Journal of Cancer|August 24, 2001
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imagingT M Moehler, H Hawighorst, K Neben, et al.
International Journal of Hematology|March 5, 2008
Successful autologous peripheral blood stem cell transplantation in a Jehovah's Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood productsS Schmitt, V Mailaender, G Egerer, et al.
European Radiology|November 1, 2014
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are takenJ Hillengass, J Stoll, C M Zechmann, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Biotechnology|December 16, 2006
Thalidomide in multiple myelomaT M Moehler, J Hillengass, A Glasmacher, et al.
Critical Reviews in Oncology/Hematology|March 14, 2003
Angiogenesis in hematologic malignanciesT M Moehler, A D Ho, H Goldschmidt, et al.
Annals of Hematology|January 18, 2002
Angiogenesis in hematologic malignanciesT M Moehler, K Neben, A D Ho, et al.
Current Pharmaceutical Design|April 14, 2004
Antiangiogenic therapy in hematologic malignanciesT M Moehler, J Hillengass, H Goldschmidt, et al.
International Journal of Hematology|October 11, 2008
Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitisJ Hillengass, A D Ho, H Goldschmidt, et al.
Blood|December 12, 2001
Salvage therapy for multiple myeloma with thalidomide and CED chemotherapyT M Moehler, K Neben, A Benner, et al.
Der Radiologe|September 28, 2000
[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma]T M Moehler, H Hawighorst, K Neben, et al.
International Journal of Cancer|August 24, 2001
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imagingT M Moehler, H Hawighorst, K Neben, et al.
International Journal of Hematology|March 5, 2008
Successful autologous peripheral blood stem cell transplantation in a Jehovah's Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood productsS Schmitt, V Mailaender, G Egerer, et al.
European Radiology|November 1, 2014
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are takenJ Hillengass, J Stoll, C M Zechmann, et al.
Pageof 2